Clinical trialNCT06340646RecruitingInterventional

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

SponsorWashington University School of MedicineEnrollment990CholangiocarcinomaColon CancerMultiple MyelomaRectal Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Graham Colditz, M.D., DrPH, MPH
Washington University School of Medicine
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Washington University School of Medicine
St Louis, Missouri, United States
Aimee James, Ph.D., MPHBettina Drake, Ph.D.David Spencer, M.D., Ph.D.Eric Duncavage, M.D.Erin Linnenbringer, Ph.D., MSFei Wan, Ph.D.Feng Chen, Ph.D.Graham Colditz, M.D., DrPH, MPHJessica Mozersky, Ph.D.Kian-Huat Lim, M.D., Ph.D.Li Ding, Ph.D.Mark Fiala, MSWMark Watson, M.D., Ph.D.Mary Politi, Ph.D.Matthew Wyczalkowski, Ph.D.Mike Wendl, DSC, MS, PHSPatricia Dickson, M.D.Ravi Vij, M.D., MBAReyka Jayasinge, Ph.D.Ryan Fields, M.D.Stephanie Solomon Cargill, Ph.D., MSPHTunji Toriola, M.D., Ph.D., MPHYin Cao, ScD, MPH
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Oct 2022
Primary completion: 31 Jan 2027
Completion: 31 Jan 2027
Last update posted: 14 Jul 2026
Registered enrollment: 990
Registry id: NCT06340646

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.